How are health care stocks doing?
Drugmakers, biotech, medical devices, health insurers and hospitals. Here is how they have done as a group against the S&P 500, and which of them are leading and lagging.
Updated Oct 9, 2026
46
Leading
Health care stocks are up 19% over the past year as an equal-weighted group, against +16% for the S&P 500. 47 of 103 beat the index. Revolution Medicines (RVMD) leads at +297% and Doximity (DOCS) trails at −59%. Over the past month the group is +3%, against +3% for the S&P.
+19% in a year104 stocksBest: RVMD +297%
Past year
Past monthThe group, equal-weighted+3%S&P 500 +3%; 40 of 104 stocks beat it
Past 3 monthsThe group, equal-weighted+8%S&P 500 +4%; 52 of 103 stocks beat it
This yearThe group, equal-weighted+16%S&P 500 +14%; 43 of 103 stocks beat it
Past yearThe group, equal-weighted+19%S&P 500 +16%; 47 of 103 stocks beat it
The past year
The group against the S&P 500, each set to $100 a year ago. Select a stock in the table to chart it against the group.
Health care stocks against the S&P 500
$100 a year ago. The group +19%, the S&P 500 +16%.
The groupS&P 500
All 104 health care stocks
Sorted by the past year’s return. Select a row to chart the stock against the group, or its ticker to open its page. Select a column to sort.
| Stock | P3 | 1M | 3M | YTD | 1Y | Type |
|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | – | −6.7% | +3% | +138% | +297% | – |
| ILMN Illumina | 80Strong | +38.2% | +46% | +112% | +184% | Distribution Top |
| NTRA Natera | 81Strong | +22.9% | +47% | +75% | +133% | Bellwether |
| ROIV Roivant Sciences | 18Weak | −13.4% | +3% | +63% | +121% | Rolling Over |
| VTRS Viatris | 42Middling | +7.7% | +8% | +42% | +77% | Exhausted Rally |
| CRL Charles River Laboratories | 55Middling | +10.5% | +31% | +51% | +74% | Faith Trade |
| CNC Centene | 81Strong | −0.1% | −4% | +59% | +70% | Distribution Top |
| BRKR Bruker | 36Middling | +9.9% | 0% | +25% | +70% | Rolling Over |
| HALO Halozyme | 62Middling | +3.2% | +45% | +64% | +69% | Hot Hand |
| MRK Merck & | 27Weak | +0.6% | +17% | +38% | +69% | Faith Trade |
| RVTY Revvity | 54Middling | +27.5% | +39% | +59% | +68% | Faith Trade |
| JAZZ Jazz Pharmaceuticals | 25Weak | −9.2% | −8% | +28% | +59% | Speculative Pop |
| RPRX Royalty Pharma | 33Middling | −3.1% | +1% | +47% | +58% | Speculative Pop |
| EXEL Exelixis | 76Strong | +4.2% | +7% | +37% | +55% | Bellwether |
| CAH Cardinal Health | 66Middling | +0.7% | +2% | +16% | +51% | Hot Hand |
| BIIB Biogen | 37Middling | +4.8% | +8% | +28% | +50% | Rolling Over |
| HUM Humana | 57Middling | +7.8% | +6% | +69% | +45% | Faith Trade |
| AMGN Amgen | 32Weak | +8.5% | +15% | +27% | +41% | Hot Hand |
| DVA DaVita | 33Weak | −1.1% | −24% | +58% | +40% | Speculative Pop |
| LLY Lilly (Eli) | 87Strong | +5.0% | 0% | +10% | +39% | Bellwether |
| JNJ Johnson & Johnson | 67Strong | −1.8% | +1% | +26% | +38% | Bellwether |
| CORT Corcept Therapeutics | 46Middling | +5.5% | +41% | +248% | +37% | Rolling Over |
| WST West Pharmaceutical Services | 27Weak | +6.3% | +2% | +33% | +37% | Hot Hand |
| OGN Organon & | 24Weak | +1.3% | +2% | +93% | +35% | Speculative Pop |
| BMY Bristol Myers Squibb | 33Weak | −7.3% | 0% | +10% | +33% | Speculative Pop |
| THC Tenet Healthcare | 27Weak | +0.1% | +35% | +33% | +32% | Speculative Pop |
| INCY Incyte | 66Middling | −8.5% | −1% | +14% | +32% | Churning Winner |
| WAT Waters | 27Weak | +8.0% | +16% | +14% | +32% | Speculative Pop |
| REGN Regeneron Pharmaceuticals | 24Weak | −5.9% | +13% | −3% | +32% | Speculative Pop |
| IQV IQVIA | 59Middling | +1.0% | +25% | +15% | +30% | Faith Trade |
| HSIC Henry Schein | 31Weak | −3.8% | −2% | +11% | +30% | Exhausted Rally |
| DGX Quest Diagnostics | 40Middling | −0.1% | +11% | +33% | +28% | Churning Winner |
| GILD Gilead Sciences | 30Weak | +4.4% | +15% | +23% | +28% | Hot Hand |
| DXCM Dexcom | 68Strong | −0.5% | +10% | +27% | +24% | Hot Hand |
| MCK McKesson | 47Middling | +6.6% | +16% | +14% | +24% | Churning Winner |
| GMED Globus Medical | 66Middling | +1.5% | −6% | −15% | +24% | Hot Hand |
| TMO Thermo Fisher Scientific | 36Middling | +9.1% | +25% | +14% | +23% | Speculative Pop |
| PEN Penumbra | 84Strong | +0.5% | 0% | +3% | +23% | Bellwether |
| UTHR United Therapeutics | 22Weak | +9.0% | +3% | +13% | +22% | Speculative Pop |
| A Agilent Technologies | 28Weak | +19.2% | +27% | +25% | +21% | Speculative Pop |
| BIO Bio-Rad Laboratories | 29Weak | −0.7% | +23% | +21% | +21% | Speculative Pop |
| BDX Becton Dickinson | 48Middling | +4.2% | +19% | +20% | +21% | Exhausted Rally |
| VRTX Vertex Pharmaceuticals | 19Weak | −0.9% | +6% | +13% | +21% | Hot Hand |
| SOLV Solventum | 47Middling | −0.4% | +13% | +10% | +21% | Faith Trade |
| TECH Bio-Techne | 26Weak | +0.5% | +2% | +23% | +20% | Speculative Pop |
| ABBV AbbVie | 48Middling | +8.4% | +11% | +21% | +20% | Hot Hand |
| MTD Mettler Toledo | 37Middling | +21.0% | +19% | +11% | +17% | Speculative Pop |
| CHE Chemed | 12Weak | −2.8% | +2% | +17% | +15% | Exhausted Rally |
| MEDP Medpace | 60Middling | +5.0% | +15% | +9% | +15% | Churning Winner |
| RGEN Repligen | 72Strong | +5.6% | +20% | +6% | +15% | Bellwether |
| ACHC Acadia Healthcare | 35Middling | +2.5% | −4% | +106% | +14% | Faith Trade |
| AVTR Avantor | 16Weak | +5.3% | +48% | +37% | +14% | Faith Trade |
| ELV Elevance Health | 60Middling | −0.9% | −3% | +18% | +14% | Bellwether |
| SHC Sotera Health | 36Middling | −1.1% | −1% | +2% | +13% | Churning Winner |
| ELAN Elanco | 61Middling | +0.3% | −9% | +1% | +13% | Distribution Top |
| EW Edwards Lifesciences | 35Middling | −1.8% | −7% | 0% | +13% | Hot Hand |
| LH Labcorp | 51Middling | +1.7% | +13% | +24% | +12% | Hot Hand |
| CVS CVS Health | 33Middling | −9.6% | −19% | +9% | +12% | Exhausted Rally |
| NVST Envista | 50Middling | −11.1% | −12% | +6% | +12% | Hot Hand |
| PFE Pfizer | 22Weak | +2.3% | +16% | +14% | +10% | Faith Trade |
| BAX Baxter International | 54Middling | +0.7% | +8% | +27% | +7% | Sleepy Staple |
| DHR Danaher | 26Weak | +9.6% | +10% | −4% | +7% | Falling Knife |
| ALGN Align Technology | 20Weak | −5.3% | −21% | −9% | +7% | Exhausted Rally |
| HCA HCA Healthcare | 38Middling | +7.1% | +15% | −3% | +6% | Show-Me Grower |
| COR Cencora | 23Weak | +0.9% | +6% | −4% | +4% | Broken Year |
| UNH UnitedHealth | 29Weak | −2.3% | −12% | +15% | +3% | Broken Year |
| NBIX Neurocrine Biosciences | 57Middling | −9.0% | −18% | 0% | +2% | Show-Me Grower |
| BMRN BioMarin Pharmaceutical | 31Weak | −16.3% | −7% | −8% | 0% | Falling Knife |
| EHC Encompass Health | 49Middling | +1.9% | +12% | +16% | −1% | Turning Up |
| VEEV Veeva Systems | 52Middling | +13.5% | +50% | +33% | −2% | Coiled Spring |
| MOH Molina Healthcare | 24Weak | −1.7% | −19% | +13% | −3% | Sleepy Staple |
| TFX Teleflex | 13Weak | −5.2% | −8% | +3% | −3% | Sleepy Staple |
| QGEN Qiagen | 19Weak | +7.7% | +10% | −4% | −5% | Falling Knife |
| ISRG Intuitive Surgical | 37Middling | +17.6% | +4% | −25% | −5% | Turning Up |
| AZN AstraZeneca | 13Weak | −0.3% | −6% | −9% | −7% | Show-Me Grower |
| CI Cigna | 40Middling | +0.5% | −7% | +3% | −8% | Show-Me Grower |
| ZBH Zimmer Biomet | 18Weak | −3.6% | −5% | −1% | −9% | Turning Up |
| CAI Caris Life Sciences | 55Middling | +23.5% | +74% | +10% | −10% | Coiled Spring |
| MDT Medtronic | 35Middling | −3.4% | +6% | −8% | −10% | Falling Knife |
| STE Steris | 51Middling | +0.9% | −1% | −15% | −12% | Wallflower |
| VKTX Viking Therapeutics | – | −11.3% | −25% | −19% | −12% | – |
| GEHC GE HealthCare | 17Weak | +2.3% | +1% | −20% | −12% | Broken Year |
| INSP Inspire Medical Systems | 49Middling | +1.1% | +34% | −25% | −12% | Coiled Spring |
| UHS Universal Health Services | 24Weak | +2.7% | +16% | −19% | −14% | Falling Knife |
| IDXX Idexx Laboratories | 47Middling | +2.3% | −8% | −23% | −18% | Coiled Spring |
| RMD ResMed | 38Middling | +4.8% | +16% | −4% | −19% | Turning Up |
| COO Cooper Companies | 16Weak | +0.4% | −24% | −34% | −23% | Broken Year |
| SRPT Sarepta Therapeutics | 36Middling | −13.0% | −5% | −17% | −24% | Bottom Fished |
| SMMT Summit Therapeutics | – | +3.5% | +15% | +1% | −25% | – |
| ABT Abbott Laboratories | 29Weak | −3.6% | +8% | −21% | −26% | Falling Knife |
| SYK Stryker | 24Weak | +2.7% | −16% | −21% | −26% | Show-Me Grower |
| XRAY Dentsply Sirona | 24Weak | −15.9% | −31% | −23% | −29% | Sleepy Staple |
| PRGO Perrigo | 16Weak | +10.8% | +48% | +8% | −30% | Bottom Fished |
| CERT Certara | 30Weak | +23.0% | +34% | +4% | −30% | Bottom Fished |
| TEM Tempus AI | 48Middling | +20.8% | +27% | +20% | −31% | Coiled Spring |
| IONS Ionis Pharmaceuticals | 20Weak | −18.6% | −20% | −43% | −35% | Show-Me Grower |
| INSM Insmed | 35Middling | −21.0% | −8% | −42% | −38% | Wallflower |
| ALNY Alnylam Pharmaceuticals | 24Weak | −6.0% | −19% | −41% | −48% | Coiled Spring |
| ZTS Zoetis | 14Weak | +2.7% | −1% | −41% | −48% | Broken Year |
| RARE Ultragenyx | 28Weak | +7.5% | −53% | −33% | −50% | Wallflower |
| BSX Boston Scientific | 18Weak | −0.9% | −4% | −55% | −56% | Coiled Spring |
| PODD Insulet | 17Weak | +0.4% | −17% | −52% | −57% | Coiled Spring |
| DOCS Doximity | 9Weak | +23.4% | +37% | −31% | −59% | Bottom Fished |
| MRNA Moderna | 21Weak | +64.7% | – | – | – | Faith Trade |
How to read this page
How it’s measured. Every stock in the Health Care sector (the GICS classification) among the S&P 500, Nasdaq-100 and Russell 1000 companies with a page here, The group is equal-weighted, so each company counts the same whatever its size, and returns are share-price changes from daily closes.
Sources. Daily prices from Financial Modeling Prep; scores from Stox.
An equal-weighted group can read quite differently from a sector fund, which gives the biggest companies the most weight.
P3 is Stox’s combined score of market beat, staying power and business growth, from 0 to 100. Type is the stock’s Stox Atlas type. Both describe the past year, not what comes next.
This page is information, not investment advice. About our data and methods ›
More sectors
How are tech stocks doing?50Leading›How are financial stocks doing?22Lagging›How are consumer discretionary stocks doing?19Lagging›How are consumer staples stocks doing?25Lagging›How are communication services stocks doing?23Lagging›How are industrial stocks doing?31Lagging›How are energy stocks doing?71Leading›How are materials stocks doing?33Lagging›How are real estate stocks doing?10Lagging›How are utility stocks doing?0Lagging›